NASHVILLE, Tenn. & BETHESDA, Md.--(BUSINESS WIRE)--Vanderbilt University Medical Center and the National Foundation for Cancer Research (NFCR) announced today the establishment of a new cancer research center that will be linked in with seven others around the world. The NFCR Center for Proteomics and Drug Actions, funded by a $1 million, 5-year grant from NFCR, will be led by Dr. Larry Marnett, Ph.D., the Mary Geddes Stahlman Professor of Cancer Research and professor of Biochemistry, Chemistry and Pharmacology at Vanderbilt University. The center will be co-directed by Dr. Dan Liebler and Dr. Richard Caprioli, also of Vanderbilt.
